FluoGuide is trading 5.82% down at SEK 34.00, with no company-specific announcement dated September 7, 2026 identified to explain the decline.

  • The stock closed at SEK 36.10 on September 4, 2026.
  • Recent H1 2026 reporting covered FDA approval for a U.S. trial site, Fast Track status, a DKK 24.6 million net loss and delayed interim results; these predate the move and do not establish causation.
  • Broader markets were mixed, while volume and activity data were unavailable.